Matū
Venture capitalAuckland · Pre-Seed–Growth
Investment thesis
Matū operates venture capital funds focused on science and deep tech companies in Aotearoa New Zealand. It takes a hands-on, active approach, backing researchers and founders working on real-world solutions to global challenges. The firm aims to turn ground-breaking scientific ideas into globally focused, IP-rich companies, drawing on decades of combined commercial and scientific experience. Portfolio companies receive strong governance, strategy, IP, and capital-raising expertise, plus access to domain experts connected to the global scientific and academic community. Matū frequently syndicates investments alongside other professional investors to reduce risk and broaden networks.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 7 of 20 portfolio companiesBiotech ×3Healthtech ×3AI & Machine Learning ×2Cleantech ×2Medical Devices ×2New Materials ×2Climate Tech ×1Deep Tech ×1
HQs:New Zealand×4Australia×1United States×1
Investments · 20 tracked
founders shown can be your intro path
Alimetry develops the Gastric Alimetry system, a non-invasive body surface gastric mapping device that provides objective diagnostics for patients with chronic gastrointestinal symptoms.
AI & Machine LearningDigital HealthHealthtechMedical DevicesAuckland, NZ
Greg O'Grady(Co-founder)Armen Gharibans(Co-founder)Karen O'Regan(CBO)Craig Shannon(CTO)Christie Dunwoodie(CFO)Christopher Andrews(CMO)
Co-investorsBooster Innovation FundCerity Partners VenturesGD1Movac
Co-investorsBooster Innovation FundCure Kids Ventures
Cloud-based software (ACABIM engine) automating compliance, auditing, and management of built assets for the AECO industries, supporting ISO-standard BIM and other open standards.
Co-investorsBooster Innovation Fund
Ferronova develops FerroTrace, a mannose-labelled iron-oxide nanoparticle tracer that maps the lymphatic network and detects high-risk lymph nodes for staging and surgical planning in patients with upper gastrointestinal cancers such as esophageal cancer.
BiotechHealthtechMedical Devices
Co-investorsBooster Innovation FundSouth Australian Venture Capital FundStoic VCUniSeed Pty Ltd.
Inhibit Coatings develops antimicrobial coatings and additives that use silver permanently bound to polymer resin to inhibit bacterial growth without leaching.
CleantechHealthtechNew MaterialsWellington, NZ
Dr Tate(Co-founder / Scientist)Prof. Johnston(Co-founder / Scientist)
Co-investorsAngel HQArc AngelsBooster Innovation FundIcehouse VenturesNZ Growth Capital Partners
Liquium develops a new catalyst technology for producing clean (zero-carbon) ammonia under milder operating conditions than the traditional Haber-Bosch process, aiming to lower production and operating costs.
CleantechClimate TechNew Materials
Dr Franck Natali(CSO & Co-Founder)Dr Paul Geraghty(CEO & Co-Founder)
Co-investorsBooster Innovation FundClimate Venture Capital Fund
Advancing gene and cell therapy delivery systems to address precision targeting challenges in living patients.
BiotechSan Francisco, US
Anil Narasimha(Executive Officer, Director)
BoardKurt Keilhacker(Director)inNeil Tiwari(Director)
Co-investorsBooster Innovation FundGood AI CapitalElementum Ventures
Opo develops bio-based ingredients and cell lines for cosmetic, medical, and cultivated meat applications using synthetic biology and biomanufacturing.
BiotechDeep TechFoodTechAuckland, NZ
Co-investorsBooster Innovation FundWNT Ventures
Commercialising soft electronics technology for robotics applications.
Co-investorsBooster Innovation FundNZ Growth Capital PartnersPacific Channel
Developing a drug to remyelinate neurons in multiple sclerosis patients.
Co-investorsBooster Innovation FundTenmile
RosterLab provides AI-powered staff rostering software that automatically generates and optimises complex schedules using a mathematical optimisation engine, handling compliance rules, skill mix, and staff preferences.
AI & Machine LearningHR TechSaaS
Co-investorsMovacPacific Channel
Early-stage company commercialising the Aloxsyn® enzyme technology that prevents and repairs lipid oxidation damage in cell membranes, initially applied to livestock fertility (AI and IVF) with broader potential in human fertility and food/beverage shelf life.
Frequently asked questions
- How many investments has Matū made?
- Matū has 20 tracked investments.
- What stage does Matū invest at?
- Matū invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Matū focus on?
- Matū focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Deep Tech, Medical Devices, New Materials.
- Where is Matū located?
- Matū is headquartered in Auckland, NZ.
- Who does Matū co-invest with?
- Matū most often shares deals with Booster Innovation Fund, Movac, NZ Growth Capital Partners, among 16 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Ontario Centre of Innovation (OCI) is a government-backed organization supporting Ontario's innovation ecosystem through funding programs and academic-industry collaboration, helping companies commercialize innovations and grow.
Seventure Partners is a European venture capital firm investing across life sciences, digital technologies, sport and performance, and the blue economy.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.